Achieve Life Sciences, Inc.

ACHV ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Jun 2, 2026 4
3 Jun 2, 2026 3
3 Jun 2, 2026 3
8-K Jun 2, 2026 8-K
PRE 14A May 29, 2026 PRE 14A
EFFECT May 21, 2026
CORRESP May 19, 2026
UPLOAD May 18, 2026
4 May 13, 2026 4
3 May 13, 2026 3
S-8 May 12, 2026 S-8
S-3 May 12, 2026 S-3
10-Q May 12, 2026 10-Q
8-K May 12, 2026 8-K
SCHEDULE 13G/A May 7, 2026
10-K/A Apr 30, 2026 10-K/A
SCHEDULE 13D Apr 27, 2026
3 Apr 27, 2026 3
SCHEDULE 13G Apr 24, 2026
SCHEDULE 13D Apr 24, 2026
3 Apr 24, 2026 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
3 Apr 24, 2026 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
SCHEDULE 13G Apr 24, 2026
SCHEDULE 13G Apr 24, 2026
4 Apr 21, 2026 4
← Newer Page 2 of 52 · 1300 filings Older →